Skip to main content
Figure 2 | Critical Care

Figure 2

From: Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury

Figure 2

Survival to day 28 according to serum NGAL. Kaplan-Meier curves of 28-day survival stratified to (a) neutrophil gelatinase-associated lipocalin (NGAL) quartiles (Q) (Log-rank (Mantel-Cox) P = 0.01; Log-rank test for trend P = 0.003), and (b) Sequential Organ Failure Assessment (SOFA) quartiles (total SOFA), respectively (Log-rank (Mantel-Cox) P = 0.01; Log-rank test for trend P = 0.002) at inception of renal replacement therapy in critically ill patients with acute kidney injury (n = 109).

Back to article page